documents: FDA-2023-N-2177-6872
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2023-N-2177-6872 | FDA | FDA-2023-N-2177 | Reference 22 - AdvaMed, “Press Release: In Congressional Testimony, AdvaMed Urges Passage of Diagnostic Regulatory Reform” | Supporting & Related Material | Background Material | 2024-05-06T04:00:00Z | 2024 | 5 | 2024-05-06T15:45:16Z | 0 | 0 | 090000648652293c |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref